Citations

Clear

3942 citation(s) found for "To, Van".

Impact of Right-sided Obstructive Lesions in Children & Adolescents having Cone Repair for Ebstein Anomaly
Hu, Jessie J. , Dorn, Charlotte S. Van , Rohatgi, Ram K., Anderson, Heather N., Wackel, Philip L. , Cetta, Frank , Johnson, Jonathan N. , Dearani, Joseph A.

Mayo Clinic

Pediatrics | March 1, 2023 | Volume: 146 | Issue: 1_MeetingAbstract | Pages: 615-616

10.1542/peds.146.1ma7.615 Get It

ImPACTS: A Collaborative Improvement Intervention Involving Children's Hospitals and General Hospitals Improves Pediatric Readiness.
Bhatnagar, Ambika , Montgomery, Erin , Sessa, Anna , Walls, Theresa A. , Landry, Kerri, Dudas, Bob, Kant, Shruti, Fenster, Daniel, Janofsky, Stephen , Walsh, Barbara , Leung, James , Ittersum, Wendy Van, Arteaga, Grace M. , Vora, Samreen , Abersol, Michelle, Auerbach, Marc , Abulebda, Kamal , Whitfill, Travis , Sessa, Anna, Scherzer, Daniel , Thomas, Anita Anne

Mayo Clinic

Pediatrics | March 1, 2023 | Volume: 146 | Issue: 1_MeetingAbstract | Pages: 203-204

10.1542/peds.146.1ma3.203 Get It

BMP2 and GDF5 for Compartmentalized Regeneration of the Scapholunate Ligament
Lui, Hayman , Vaquette, Cedryck , Denbeigh, Janet M. , Bindra, Randy , Wijnen, André J. van , Kakar, Sanjeev , Kakar, Sanjeev , van Wijnen, Andre J , van Wijnen, Andre J , Vaquette, Cédryck

Mayo Clinic

Journal of Wrist Surgery | March 1, 2023 | Volume: 12 | Issue: 05 | Pages: 418-427

10.1055/s-0043-1761608 | PMID 37841358 Get It

Abstract Background Chronic injuries to the scapholunate ligament (SLIL) alter carpal kinematics and may progress to early degenerative osteoarthritis. To date, there is no consensus for the best method for SLIL reconstruction. This study aims to assess the use of growth factors (bone morphogenetic protein [BMP]2 and growth and differentiation factor 5 [GDF5]) for compartmentalized regeneration of bone and ligament in this multiphasic scaffold in a rabbit knee model. Case Description A total of 100 µg of BMP2 and 30 µg of GDF5 were encapsulated into a heparinized gelatin–hyaluronic acid hydrogel and loaded into the appropriate compartment of the multiphasic scaffold. The multiphasic scaffold was implanted to replace the native rabbit medial collateral ligament (n = 16). The rabbits were randomly assigned to two different treatment groups. The first group was immobilized postoperatively with the knee pinned in flexion with K-wires for 4 weeks (n = 8) prior to sacrifice. The second group was immobilized for 4 weeks, had the K-wires removed followed by a further 4 weeks of mobilization prior to sample harvesting. Literature Review Heterotopic ossification as early as 4 weeks was noted on gross dissection and confirmed by microcomputed tomography and histological staining. This analysis revealed formation of a bony bridge located within and over the ligament compartment in the intra-articular region. Biomechanical testing showed increased ultimate force of the ligament compartment at 4 weeks postimplantation consistent with the presence of bone formation and higher numbers of scaffold failures at the bone–tendon junction. This study has demonstrated that the addition of BMP2 and GDF5 in the bone–ligament–bone (BLB) scaffold resulted in heterotopic bone formation and failure of the ligament compartment. Clinical Relevance The implantation of a three-dimensional-printed BLB scaffold alone demonstrated superior biomechanical and histological results, and further investigation is needed as a possible clinical reconstruction for the SLIL.
ICU Outcomes for Cone Reconstruction in Children with Ebstein Anomaly
Anderson, Heather N., Dorn, Charlotte S. Van , Haggerty, Brielle J., Wackel, Philip L. , Cetta, Frank , Johnson, Jonathan N. , Dearani, Joseph A. , Nemergut, Michael E.

Mayo Clinic

Pediatrics | February 28, 2023 | Volume: 144 | Issue: 2_MeetingAbstract | Pages: 318-318

10.1542/peds.144.2ma4.318b Get It

Impact of Left-sided Lesions in Pediatric Patients Having Surgery for Ebstein Anomaly
Haggerty, Brielle J., Dorn, Charlotte S. Van , Anderson, Heather N., Wackel, Philip L. , Cetta, Frank , Johnson, Jonathan N. , Dearani, Joseph A.

Mayo Clinic

Pediatrics | February 28, 2023 | Volume: 144 | Issue: 2_MeetingAbstract | Pages: 294-294

10.1542/peds.144.2ma3.294 Get It

Update of penetrance estimates in Birt-Hogg-Dubé syndrome
Bruinsma, Fiona , Dowty, James G., Win, Aung Ko , Goddard, Laura C, Agrawal, Prachi , Attinà, Domenico , Bissada, Nabil K., Eisen, Daniel B. , Furuya, Mitsuko , Hansen, Thomas van Overeem , Houweling, Arjan C. , Johannesma, Paul C., Lim, Derek H.K., Lindor, Noralane M. , Luzzi, Valentina , Lynch, Maeve , Maffé, Antonella, Menko, Fred H. , Michels, Guido, Pulido, José S. , Ryu, Jay H. , Sattler, Elke , Steinlein, Ortrud K. , Tucker, Kathy , Beek, Irma van de , Riel, Lore van , Zénone, Thierry, Zompatori, Maurizo, Bondavalli, Davide , I-CONFIRM, Genetic Susceptibility Working Group, Bruinsma, Fiona Jane , Turchetti, Daniela , Maher, Eamonn R , Win, Aung K , Ryu, Jay H , Hansen, Thomas van Overeem , Luise, Monica De , Gasparre, Giuseppe , Genuardi, Maurizio , Gerdes, Anne‐Marie , Lencastre, André , Tomassetti, Sara , Steensel, Maurice A. M. Van , Zompatori, Maurizio , Walsh, Jennifer, Maher, Eamonn R. , Winship, Ingrid , I-CONFIRM, Genetic Susceptibility Working Group

Mayo Clinic

Journal of Medical Genetics | February 27, 2023 | Volume: 60 | Issue: 4 | Pages: 317-326

10.1136/jmg-2022-109104 | PMID 36849229 Get It

Background Birt-Hogg-Dubé (BHD) syndrome is a rare genetic syndrome caused by pathogenic or likely pathogenic germline variants in the FLCN gene. Patients with BHD syndrome have an increased risk of fibrofolliculomas, pulmonary cysts, pneumothorax and renal cell carcinoma. There is debate regarding whether colonic polyps should be added to the criteria. Previous risk estimates have mostly been based on small clinical case series. Methods A comprehensive review was conducted to identify studies that had recruited families carrying pathogenic or likely pathogenic variants in FLCN . Pedigree data were requested from these studies and pooled. Segregation analysis was used to estimate the cumulative risk of each manifestation for carriers of FLCN pathogenic variants. Results Our final dataset contained 204 families that were informative for at least one manifestation of BHD (67 families informative for skin manifestations, 63 for lung, 88 for renal carcinoma and 29 for polyps). By age 70 years, male carriers of the FLCN variant have an estimated 19% (95% CI 12% to 31%) risk of renal tumours, 87% (95% CI 80% to 92%) of lung involvement and 87% (95% CI 78% to 93%) of skin lesions, while female carriers had an estimated 21% (95% CI 13% to 32%) risk of renal tumours, 82% (95% CI 73% to 88%) of lung involvement and 78% (95% CI 67% to 85%) of skin lesions. The cumulative risk of colonic polyps by age 70 years old was 21% (95% CI 8% to 45%) for male carriers and 32% (95% CI 16% to 53%) for female carriers. Conclusions These updated penetrance estimates, based on a large number of families, are important for the genetic counselling and clinical management of BHD syndrome.
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma
Duin, Isabella A.J. van , Elias, Sjoerd G. , Eertwegh, Alfonsus Johannes Maria van den, Groot, Jan Willem B. de , Diest, P. J. van , Verheijden, Rik J. , Not, Olivier J. van , Aarts, Maureen J.B. , Berkmortel, Franchette W.P.J. van den , Blank, Christian U. , Kamphuis, Anna M., Piersma, Djura , Rijn, Rozemarijn S. van, Veldt, Astrid A.M. van der , Vreugdenhil, Gerard , Boer, Marion A. M. Stevense‐den, Boers‐Sonderen, Marye J. , Kapiteijn, Ellen , van Duin, Isabella A J , van Diest, Paul J , Blokx, Willeke A.M. , Leiner, Tim , Verhoeff, Joost J.C. , Haanen, John B A G , Hospers, Geke A.P. , Wouters, Michel W.J.M. , Suijkerbuijk, Karijn P.M.

Mayo Clinic

International Journal of Cancer | February 27, 2023 | Volume: 152 | Issue: 12 | Pages: 2493-2502

10.1002/ijc.34479 | PMID 36843274 Get It

AbstractSince the introduction of BRAF(/MEK) inhibition and immune checkpoint inhibition (ICI), the prognosis of advanced melanoma has greatly improved. Melanoma is known for its remarkably long time to first distant recurrence (TFDR), which can be decades in some patients and is partly attributed to immune‐surveillance. We investigated the relationship between TFDR and patient outcomes after systemic treatment for advanced melanoma. We selected patients undergoing first‐line systemic therapy for advanced melanoma from the nationwide Dutch Melanoma Treatment Registry. The association between TFDR and progression‐free survival (PFS) and overall survival (OS) was assessed by Cox proportional hazard regression models. The TFDR was modeled categorically, linearly, and flexibly using restricted cubic splines. Patients received anti‐PD‐1‐based treatment (n = 1844) or BRAF(/MEK) inhibition (n = 1618). For ICI‐treated patients with a TFDR <2 years, median OS was 25.0 months, compared to 37.3 months for a TFDR >5 years (P = .014). Patients treated with BRAF(/MEK) inhibition with a longer TFDR also had a significantly longer median OS (8.6 months for TFDR <2 years compared to 11.1 months for >5 years, P = .004). The hazard of dying rapidly decreased with increasing TFDR until approximately 5 years (HR 0.87), after which the hazard of dying further decreased with increasing TFDR, but less strongly (HR 0.82 for a TFDR of 10 years and HR 0.79 for a TFDR of 15 years). Results were similar when stratifying for type of treatment. Advanced melanoma patients with longer TFDR have a prolonged PFS and OS, irrespective of being treated with first‐line ICI or targeted therapy.
Radiographic predictors of occult intracranial involvement in olfactory neuroblastoma patients
Geltzeiler, Mathew , Ji, Keven Seung Yong , JessMace, C., Almeida, John R. de , Champagne, Pierre‐Olivier , Chan, Erik, Ciporen, Jeremy , Chaskes, Mark B., Cornell, Sarah, Drozdowski, Veronica , Fernandez‐Miranda, Juan C. , Gardner, Paul A. , Hwang, Peter H. , Kalyvas, Aristotelis , Kong, Keonho A., McMillan, Ryan A. , Patel, Chirag , Patel, Zara M. , Celda, María Peris, Sanusi, Olabisi , Thorp, Brian D. , Zadeh, Gelareh , Zenonos, Georgios A. , Zwagerman, Nathan T. , Choby, Garret , Almeida, João Paulo , McMillan, Ryan A , Nayak, Jayakar V , Patel, Zara , Pinheiro-Neto, Carlos, Snyderman, Carl H , Wang, Eric W , Hwang, Peter H , Geltzeiler, Mathew , Choby, Garret , Nayak, Jayakar V. , Pinheiro‐Neto, Carlos , Gompel, Jamie J. Van

Mayo Clinic

International Forum of Allergy & Rhinology | February 26, 2023 | Volume: 13 | Issue: 10 | Pages: 1876-1888

10.1002/alr.23145 | PMID 36841933 Get It

AbstractBackgroundTraditional management of olfactory neuroblastoma (ONB) includes margin‐negative resection with removal of cribriform plate, dura, and olfactory bulb, regardless of intracranial disease. This approach may be overtreating certain patients. Our investigation examines risk factors associated with occult intracranial disease to optimize therapeutic outcomes.MethodsThis retrospective, multi‐institutional cohort study examined clinical covariates associated with occult intracranial involvement. Patient demographics, staging, Hyam's grade, and pathologic involvement of dura, olfactory bulb/tract, and brain were collected. Diagnostic imaging was reviewed. Positive and negative predictive value (NPV) were estimated along with effect size estimates. Cox hazard regression examined associations with overall survival (OS) and disease‐free survival (DFS).ResultsA total of 224 subjects with new diagnoses of ONB (2005–2021) were identified. Skull base bone involvement on computed tomography (CT) had the highest NPV for pathologic dura (88.0%), olfactory bulb (88%), and brain involvement (97.3%). Hyam's grade category was significantly associated with dural involvement (φC = 0.26; 95% confidence interval [CI]: 0.16, 0.42). Subjects without radiologic skull base involvement (n = 66) had pathologic positivity of 12.1%. Within this subgroup, Hyam's grade was clinically significant for dural positivity (φ = 0.34; 95% CI: −0.12, 0.71) with 28.6% involvement in high grade tumors. Neither clinical nor pathologic positivity of intracranial structures were associated with significantly different OS or DFS.ConclusionsBoth CT and magnetic resonance imaging (MRI) had reasonably good NPV for involvement of dura and olfactory bulb. Higher Hyam's grade was associated with dural involvement. Patients with low‐grade tumors not involving the skull base may be suitable for avoiding skull base resection; however, further investigation is warranted.
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Zhu, Bibo , Wei, Xiaoqin , Narasimhan, Harish , Qian, Wei , Zhang, Ruixuan , Cheon, In Su , Wu, Yue , Li, Chaofan , Jones, Russell G. , Kaplan, Mark H. , Vassallo, Robert , Braciale, Thomas J. , Somerville, Lindsay , Colca, Jerry R. , Pandey, Akhilesh , Jackson, Patrick , Mann, Barbara J. , Sun, Jie , Vassallo, Robert , Jackson, Patrick E H , Krawczyk, Connie M , Sturek, Jeffrey M , Sun, Jie , Pandey, Akhilesh , Kaplan, Mark H , Jones, Russell G , Li, Chaofan , Somerville, Lindsay A , Zhang, Ruixuan

Mayo Clinic

Science Immunology | February 23, 2023 | Volume: 8 | Issue: 82 | Pages: No page available

10.1126/sciimmunol.adf0348 | PMID 36821695 Get It

The relationship between diabetes and coronavirus disease 2019 (COVID-19) is bidirectional: Although individuals with diabetes and high blood glucose (hyperglycemia) are predisposed to severe COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can also cause hyperglycemia and exacerbate underlying metabolic syndrome. Therefore, interventions capable of breaking the network of SARS-CoV-2 infection, hyperglycemia, and hyperinflammation, all factors that drive COVID-19 pathophysiology, are urgently needed. Here, we show that genetic ablation or pharmacological inhibition of mitochondrial pyruvate carrier (MPC) attenuates severe disease after influenza or SARS-CoV-2 pneumonia. MPC inhibition using a second-generation insulin sensitizer, MSDC-0602K (MSDC), dampened pulmonary inflammation and promoted lung recovery while concurrently reducing blood glucose levels and hyperlipidemia after viral pneumonia in obese mice. Mechanistically, MPC inhibition enhanced mitochondrial fitness and destabilized hypoxia-inducible factor–1α, leading to dampened virus-induced inflammatory responses in both murine and human lung macrophages. We further showed that MSDC enhanced responses to nirmatrelvir (the antiviral component of Paxlovid) to provide high levels of protection against severe host disease development after SARS-CoV-2 infection and suppressed cellular inflammation in human COVID-19 lung autopsies, demonstrating its translational potential for treating severe COVID-19. Collectively, we uncover a metabolic pathway that simultaneously modulates pulmonary inflammation, tissue recovery, and host metabolic health, presenting a synergistic therapeutic strategy to treat severe COVID-19, particularly in patients with underlying metabolic disease.
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis
Grossmann, Nico C. , Juvet, Tristan , Potretzke, Aaron M. , Djaladat, Hooman , Ghoreifi, Alireza , Mari, Andrea , Fujita, Kazutoshi , Fontana, Matteo , Sfakianos, John P. , Pfail, John , Laukhtina, Ekaterina , Rajwa, Paweł , Pallauf, Maximillian, Poyet, Cédric , Cacciamani, Giovanni , Doeveren, Thomas van , Boormans, Joost L., Antonelli, Alessandro , Jamil, Marcus , Abdollah, Firas , Ploussard, Guillaume , Heidenreich, Axel , Storz, Enno , Boorjian, Stephen A. , Rink, Michael , Shariat, Shahrokh F. , Pradère, Benjamin , Ghoreifi, Alireza , Mari, Andrea , Fujita, Kazutoshi , Fontana, Matteo , Laukhtina, Ekaterina , Cacciamani, Giovanni E , Boormans, Joost L , Antonelli, Alessandro , Abdollah, Firas , Ploussard, Guillaume , Shariat, Shahrokh F , Pradere, Benjamin , Grossman, Nico C , Rajwa, Pawel , Soria, Francesco , Kikuchi, Eiji , Khene, Z. , Raman, Jay D. , Breda, Alberto , Daneshmand, Siamak , Rouprêt, Morgan

Mayo Clinic

Cancers | February 23, 2023 | Volume: 15 | Issue: 5 | Pages: 1409

10.3390/cancers15051409 | PMID 36900201 Get It

Objectives: To identify correlates of survival and perioperative outcomes of upper tract urothelial carcinoma (UTUC) patients undergoing open (ORNU), laparoscopic (LRNU), and robotic (RRNU) radical nephroureterectomy (RNU). Methods: We conducted a retrospective, multicenter study that included non-metastatic UTUC patients who underwent RNU between 1990–2020. Multiple imputation by chained equations was used to impute missing data. Patients were divided into three groups based on their surgical treatment and were adjusted by 1:1:1 propensity score matching (PSM). Survival outcomes per group were estimated for recurrence-free survival (RFS), bladder recurrence-free survival (BRFS), cancer-specific survival (CSS), and overall survival (OS). Perioperative outcomes: Intraoperative blood loss, hospital length of stay (LOS), and overall (OPC) and major postoperative complications (MPCs; defined as Clavien–Dindo > 3) were assessed between groups. Results: Of the 2434 patients included, 756 remained after PSM with 252 in each group. The three groups had similar baseline clinicopathological characteristics. The median follow-up was 32 months. Kaplan–Meier and log-rank tests demonstrated similar RFS, CSS, and OS between groups. BRFS was found to be superior with ORNU. Using multivariable regression analyses, LRNU and RRNU were independently associated with worse BRFS (HR 1.66, 95% CI 1.22–2.28, p = 0.001 and HR 1.73, 95%CI 1.22–2.47, p = 0.002, respectively). LRNU and RRNU were associated with a significantly shorter LOS (beta −1.1, 95% CI −2.2–0.02, p = 0.047 and beta −6.1, 95% CI −7.2–5.0, p < 0.001, respectively) and fewer MPCs (OR 0.5, 95% CI 0.31–0.79, p = 0.003 and OR 0.27, 95% CI 0.16–0.46, p < 0.001, respectively). Conclusions: In this large international cohort, we demonstrated similar RFS, CSS, and OS among ORNU, LRNU, and RRNU. However, LRNU and RRNU were associated with significantly worse BRFS, but a shorter LOS and fewer MPCs.